Avant Technologies Signs Joint Venture to Advance Cell-Based Diabetes Treatment

Go back to Avant Technologies Signs Joint Venture to Advance Cell-Based Diabetes Treatment
(AMEX: AVAI) Delayed: 0.12 --0 (-0%)
Previous Close $0.12    52 Week High
Open $0.12    52 Week Low
Day High $0.13    P/E N/A 
Day Low $0.11    EPS
Volume 81,175